The Single use Bioreactors Market size was estimated at USD 2.8 billion in 2023 and is projected to reach USD 6.5 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.50% during the forecast period (2024-2030).

Single use Bioreactors Market

Market Summary

The single use bioreactors market represents a transformative segment within the biotechnology industry, characterized by the adoption of disposable culture systems for cell cultivation and bioprocessing. These systems are designed for one-time use, eliminating the need for cleaning and sterilization between batches, which significantly reduces the risk of cross-contamination and enhances operational efficiency. The market is primarily driven by the expanding biopharmaceutical sector, where the demand for monoclonal antibodies, vaccines, and other biologics is escalating. Manufacturers and contract development and manufacturing organizations (CDMOs) are increasingly integrating single use technologies into their production workflows to achieve greater flexibility, reduce capital investment, and accelerate time-to-market for new therapies. The technology is applicable across various scales, from research and development to commercial production, making it a versatile solution for modern bioprocessing challenges. Key industry players are continuously innovating to improve bioreactor design, sensor integration, and scalability to meet the evolving needs of the market.

Key Highlights

The single use bioreactors market is distinguished by several key highlights that underscore its growing importance in bioprocessing. A significant advantage is the drastic reduction in validation and cleaning requirements, which translates to lower operational costs and decreased water and energy consumption, aligning with sustainability goals. These systems offer unparalleled flexibility, allowing facilities to quickly switch between production campaigns for different products without extensive downtime. Technological advancements have led to the development of sophisticated single use bioreactors capable of supporting high cell density cultures and precise process control, rivaling the performance of traditional stainless-steel systems. The market has seen increased adoption in emerging applications such as cell and gene therapy production, where product safety and speed are paramount. Furthermore, the supply chain for single use components and assemblies has become more robust and reliable, ensuring consistent availability for end-users. Leading companies are also focusing on developing integrated solutions that combine bioreactors with downstream processing units, creating more efficient end-to-end single use bioprocessing platforms.

Drivers, Opportunities & Restraints

The growth of the single use bioreactors market is propelled by several powerful drivers. The rising prevalence of chronic diseases is fueling the demand for biopharmaceuticals, necessitating efficient and scalable manufacturing solutions. The cost advantages associated with single use systems, including lower capital expenditure and reduced utility costs, make them highly attractive, especially for small and mid-sized biotech companies. The stringent regulatory requirements for product quality and safety further encourage adoption, as disposable systems minimize contamination risks. Significant opportunities exist in the expansion of personalized medicine and orphan drugs, which often require smaller, more flexible production batches ideally suited for single use technology. The emergence of novel therapies in areas like regenerative medicine presents a new frontier for market growth. However, the market faces certain restraints. Concerns regarding extractables and leachables from plastic components remain a critical consideration for regulatory compliance and product integrity. The dependence on a limited number of suppliers for raw materials like plastic films and bags can pose supply chain vulnerabilities. Furthermore, the environmental impact of plastic waste generated from disposable systems is becoming a greater focus, pushing the industry towards developing more sustainable disposal and recycling options.

Concentration Insights

The competitive landscape of the single use bioreactors market is characterized by a high degree of concentration, with a few major players holding a significant share of the global market. These leading companies possess extensive product portfolios, robust intellectual property, and a strong global presence, giving them a competitive edge. Key players such as Sartorius AG, Danaher Corporation (through its subsidiary Cytiva), and Thermo Fisher Scientific Inc. dominate through continuous innovation, strategic acquisitions, and partnerships. These established entities offer integrated solutions that encompass bioreactors, sensors, controllers, and ancillary disposable items, creating a compelling value proposition for customers. Alongside these giants, several specialized and emerging companies are carving out niches by focusing on specific technologies, such as wave-induced motion systems or novel bag designs for specialized applications. The market also sees active participation from companies providing critical components like single use bags and sensors, which are essential for the ecosystem. This concentration fosters a environment of intense R&D and technological advancement, but also necessitates that new entrants offer highly differentiated and innovative products to gain market traction.

Type Insights

Single use bioreactors are available in various types, each tailored to specific process requirements and scales of operation. Stirred-tank single use bioreactors are among the most prevalent, mimicking the design of traditional stainless-steel tanks with an impeller for agitation. They are widely used for their excellent mixing and mass transfer capabilities, suitable for a broad range of cell cultures including mammalian and insect cells. Wave-induced motion bioreactors utilize a rocking platform to generate waves in the culture bag, providing gentle mixing ideal for shear-sensitive cells, such as those used in cell therapy applications. These are often preferred at smaller scales for process development and seed train applications. Other types include bubble column bioreactors, which use gas sparging for mixing and are simple in design, and hybrid systems that may combine elements of different technologies. The choice of bioreactor type is influenced by factors such as cell line sensitivity, oxygen transfer demands, desired culture volume, and the specific end product being manufactured. Manufacturers are continually refining each type to enhance performance, scalability, and user-friendliness.

Application Insights

The application of single use bioreactors spans the entire biopharmaceutical development and manufacturing pipeline, demonstrating remarkable versatility. In research and development, they are indispensable tools for process optimization, clone screening, and production of materials for pre-clinical studies due to their quick setup and minimal resource requirement. For commercial production, they are increasingly deployed for manufacturing monoclonal antibodies, recombinant proteins, and vaccines, offering the scalability needed to meet market demand. A rapidly growing application area is in the production of advanced therapy medicinal products (ATMPs), including cell and gene therapies. The closed and sterile nature of single use systems is critical for maintaining the integrity and safety of these often patient-specific therapies. Beyond therapeutics, these bioreactors find use in the production of industrial enzymes and various bio-based chemicals. The flexibility of the technology allows for its use in both fed-batch and perfusion processes, catering to the specific metabolic needs of different cell cultures and maximizing product yields.

Regional Insights

Adoption and growth of the single use bioreactors market vary significantly across different geographic regions, influenced by local biopharmaceutical industry maturity, regulatory frameworks, and investment in research. North America, particularly the United States, represents the largest and most mature market. This dominance is attributed to a strong presence of leading biopharmaceutical companies, high R&D expenditure, and a supportive regulatory environment that encourages technological innovation. Europe follows closely, with countries like Germany, Switzerland, and the UK being major hubs for biomanufacturing and home to several key equipment manufacturers. The Asia Pacific region is identified as the fastest-growing market, driven by increasing investments in healthcare infrastructure, growing biopharmaceutical outsourcing to countries like China and India, and government initiatives supporting the biotechnology sector. Emerging economies in Latin America and the Middle East and Africa are also beginning to show increased adoption, though at a slower pace, as they develop their local biomanufacturing capabilities and expertise.

Company Insights

The single use bioreactors market features a dynamic mix of global life science giants and specialized technology providers. Sartorius AG is a foremost leader, offering a comprehensive range of bioreactors under its Biostat STR and Biostat RM series, alongside advanced control systems. Danaher Corporation, operating through its Cytiva business, is another dominant force with its Xcellerex product line, known for its scalability and performance. Thermo Fisher Scientific Inc. provides robust solutions through its HyPerforma single use bioreactors, integrated with its extensive portfolio of cell culture media and supplements. Merck KGaA also holds a significant position with its Mobius line of single use products. Beyond these majors, companies like Eppendorf AG, Distek Inc., and PBS Biotech Inc. have established strong reputations by offering innovative and often specialized systems that cater to specific customer needs, particularly in the areas of high-density culture and specialized mixing. The competitive strategies primarily revolve around product innovation, expansion of capacity and scalability options, and forming strategic partnerships with end-users and CDMOs.

Recent Developments

The single use bioreactors market is evolving rapidly, with recent developments focusing on enhancing capacity, integration, and sustainability. A prominent trend is the push towards larger working volumes, with manufacturers introducing systems capable of handling volumes of 2000 liters and beyond to meet the demands of commercial-scale production. There is a significant emphasis on integrating advanced process analytical technology (PAT) tools directly into single use assemblies. This includes sensors for real-time monitoring of critical parameters like pH, dissolved oxygen, and glucose, enabling better process control and facilitating the adoption of Quality by Design (QbD) principles. Another key development area is the creation of more connected and automated systems that can seamlessly integrate with manufacturing execution systems (MES) for improved data management and operational efficiency. Furthermore, addressing environmental concerns, companies are investing in research to develop bio-based or more readily recyclable plastics for single use bags and are establishing take-back programs to manage plastic waste more responsibly.

Report Segmentation

This market research report on the single use bioreactors market provides a detailed and structured analysis segmented to offer granular insights. The segmentation is typically based on several core parameters to cater to the diverse information needs of stakeholders. The report is segmented by product type, categorizing the market into stirred-tank single use bioreactors, wave-induced motion systems, bubble column bioreactors, and other hybrid or specialized designs. It is further segmented by scale of operation, distinguishing between laboratory-scale, pilot-scale, and large-scale or commercial-scale production systems. Application-based segmentation covers the production of monoclonal antibodies, vaccines, cell and gene therapies, recombinant proteins, and other applications like industrial enzymes. The end-user segment analysis focuses on biopharmaceutical companies, contract research and manufacturing organizations (CROs and CDMOs), and academic and research institutes. Finally, the report provides a thorough geographical segmentation, breaking down the market into key regions and countries to analyze regional trends, growth patterns, and opportunities. This multi-faceted segmentation allows for a comprehensive understanding of the market dynamics from every relevant angle.

FAQs

What are the advantages of single-use bioreactors over stainless steel? Single-use bioreactors offer significant advantages including elimination of cleaning and sterilization validation, reduced risk of cross-contamination, lower capital investment, increased operational flexibility for multi-product facilities, faster turnaround between batches, and decreased water and utility consumption.

What cells are cultured in single-use bioreactors? Single-use bioreactors are versatile and used to culture a wide array of cell types. This includes mammalian cells (e.g., CHO, HEK293) for producing monoclonal antibodies and recombinant proteins, insect cells for viral vector production, human cells for cell therapies, and also microbial cells like bacteria and yeast for certain applications.

What is the difference between a bioreactor and a fermenter? The terms are often used interchangeably, but a technical distinction exists. A bioreactor is a broad term for any vessel used to grow biological organisms, including animal, plant, and insect cells. A fermenter is specifically designed for growing anaerobic microorganisms, like bacteria and yeast, typically for industrial applications such as ethanol production.

What are the limitations of single-use bioreactors? Key limitations include concerns regarding leachables and extractables from plastic components, potential supply chain constraints for raw materials, limitations on maximum culture volume compared to very large stainless-steel tanks, and challenges associated with the environmental impact of plastic waste disposal.

Who are the leading manufacturers of single-use bioreactors? The market is led by major life science corporations including Sartorius AG, Danaher Corporation (through its Cytiva brand), and Thermo Fisher Scientific Inc. Other significant players include Merck KGaA, Eppendorf AG, and PBS Biotech Inc.

How are single-use bioreactors used in vaccine production? They are extensively used in vaccine production for cultivating the cells or microorganisms that produce the vaccine antigens. Their closed and sterile nature is crucial for maintaining aseptic conditions, and their flexibility allows manufacturers to rapidly scale up production in response to pandemics or seasonal demand fluctuations.

Citius Research has developed a research report titled “Single use Bioreactors Market Report - Global Industry Analysis, Size, Share, Growth Trends, Regional Outlook, Competitive Strategies and Segment Forecasts 2024 - 2030” delivering key insights regarding business intelligence and providing concrete business strategies to clients in the form of a detailed syndicated report. The report details out the factors such as business environment, industry trend, growth opportunities, competition, pricing, global and regional market analysis, and other market related factors.

Details included in the report for the years 2024 through 2030

• Single use Bioreactors Market Potential
• Segment-wise breakup
• Compounded annual growth rate (CAGR) for the next 6 years
• Key customers and their preferences
• Market share of major players and their competitive strength
• Existing competition in the market
• Price trend analysis
• Key trend analysis
• Market entry strategies
• Market opportunity insights

The report focuses on the drivers, restraints, opportunities, and challenges in the market based on various factors geographically. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report. The Single use Bioreactors Market report is segmented on the basis of various market segments and their analysis, both in terms of value and volume, for each region for the period under consideration.

Single use Bioreactors Market Segmentation

Regions Covered

• North America
• Latin America
• Europe
• MENA
• Asia Pacific
• Sub-Saharan Africa and
• Australasia

Single use Bioreactors Market Analysis

The report covers below mentioned analysis, but is not limited to:

• Overview of Single use Bioreactors Market
• Research Methodology
• Executive Summary
• Market Dynamics of Single use Bioreactors Market
  • Driving Factors
  • Restraints
  • Opportunities
• Global Market Status and Forecast by Segment A
• Global Market Status and Forecast by Segment B
• Global Market Status and Forecast by Segment C
• Global Market Status and Forecast by Regions
• Upstream and Downstream Market Analysis of Single use Bioreactors Market
• Cost and Gross Margin Analysis of Single use Bioreactors Market
• Single use Bioreactors Market Report - Global Industry Analysis, Size, Share, Growth Trends, Regional Outlook, Competitive Strategies and Segment Forecasts 2024 - 2030
  • Competition Landscape
  • Market Share of Major Players
• Key Recommendations

The “Single use Bioreactors Market Report - Global Industry Analysis, Size, Share, Growth Trends, Regional Outlook, Competitive Strategies and Segment Forecasts 2024 - 2030” report helps the clients to take business decisions and to understand strategies of major players in the industry. The report delivers the market driven results supported by a mix of primary and secondary research. The report provides the results triangulated through authentic sources and upon conducting thorough primary interviews with the industry experts. The report includes the results on the areas where the client can focus and create point of parity and develop a competitive edge, based on real-time data results.

Single use Bioreactors Market Key Stakeholders

Below are the key stakeholders for the Single use Bioreactors Market:

• Manufacturers
• Distributors/Traders/Wholesalers
• Material/Component Manufacturers
• Industry Associations
• Downstream vendors

Single use Bioreactors Market Report Scope

COVID-19 Impact Analysis

Like most other markets, the outbreak of COVID-19 had an unfavorable impact on the Single use Bioreactors Market worldwide. This report discusses in detail the disruptions experienced by the market, the impact on flow of raw materials, manufacturing operations, production trends, consumer demand and the projected future of this market post pandemic.

The report has helped our clients:

• To describe and forecast the Single use Bioreactors Market size, on the basis of various segmentations and geography, in terms of value and volume
• To measure the changing needs of customers/industries
• To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the market
• To gain competitive intelligence and uncover new opportunities
• To analyse opportunities in the market for stakeholders by identifying high-growth segments in Single use Bioreactors Market
• To strategically profile key players and provide details of the current competitive landscape
• To analyse strategic approaches adopted by players in the market, such as product launches and developments, acquisitions, collaborations, contracts, expansions, and partnerships

Report Customization

Citius Research provides free customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Frequently Asked Questions